P

Protagonist Therapeutics

D

PTGX

USD

1.2

(2.6846%)

Market Closed

28,499.00

حجم التداول

1.44

الربح لكل سهم

-

العائد الربحي

16.835

P/E

2,703,720,451.50

حجم السوق

اليوم

2.6846%

1 اسبوع

0.548%

1 شهر

9.599%

6 اشهر

59.264%

12 اشهر

159.762%

بداية السنة

100.131%

كل الوقت

0%

أصول ذات صلة

Title:
Protagonist Therapeutics

Sector:

Healthcare

Industry:

Biotechnology

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Itspipeline products include Rusfertide (PTG-300) and JNJ-2113.

هل تحتاج مساعدة او لديك استفسار؟

تواصل معنا